|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
94 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Acknowledgements |
|
19 | S4 |
p. iv4-iv5 |
artikel |
||
| 2 | aggressive lymphoma |
|
19 | S4 |
p. iv141-iv152 |
artikel |
||
| 3 | aggressive lymphoma |
|
19 | S4 |
p. iv216-iv222 |
artikel |
||
| 4 | amgen |
|
19 | S4 |
p. iv257-iv258 |
artikel |
||
| 5 | Amyloidosis: is a cure possible? |
Merlini, G. |
|
19 | S4 |
p. iv63-iv66 |
artikel |
|
| 6 | author index |
|
19 | S4 |
p. iv277-iv291 |
artikel |
||
| 7 | Autoimmune disorders and lymphoma |
Caligaris-Cappio, F. |
|
19 | S4 |
p. iv31-iv34 |
artikel |
|
| 8 | Bayer Schering Pharma |
|
19 | S4 |
p. iv276 |
artikel |
||
| 9 | bayer schering pharma |
|
19 | S4 |
p. iv270 |
artikel |
||
| 10 | Bing Center for Waldenström's macroglobulinemia update on plasma cell disorders |
|
19 | S4 |
p. iv267-iv269 |
artikel |
||
| 11 | biogen idec oncology |
|
19 | S4 |
p. iv264 |
artikel |
||
| 12 | Burkitt lymphoma versus diffuse large B-cell lymphoma |
Rosenwald, A. |
|
19 | S4 |
p. iv67-iv69 |
artikel |
|
| 13 | celgene |
|
19 | S4 |
p. iv271-iv272 |
artikel |
||
| 14 | celgene |
|
19 | S4 |
p. iv254 |
artikel |
||
| 15 | cephalon oncology |
|
19 | S4 |
p. iv255-iv256 |
artikel |
||
| 16 | CLL |
|
19 | S4 |
p. iv204-iv206 |
artikel |
||
| 17 | CLL |
|
19 | S4 |
p. iv192-iv196 |
artikel |
||
| 18 | Conference Schedule |
|
19 | S4 |
p. iv9-iv29 |
artikel |
||
| 19 | controversy I: do we need radiotherapy in early HL? |
|
19 | S4 |
p. iv82 |
artikel |
||
| 20 | controversy II: has PET changed the approach to lymphoma patients? |
|
19 | S4 |
p. iv122 |
artikel |
||
| 21 | Current treatment standards and future strategies in mantle cell lymphoma |
Dreyling, M. |
|
19 | S4 |
p. iv41-iv44 |
artikel |
|
| 22 | Editorial Board |
|
19 | S4 |
p. i, iii |
artikel |
||
| 23 | epidemiology |
|
19 | S4 |
p. iv197-iv198 |
artikel |
||
| 24 | extranodal lymphoma |
|
19 | S4 |
p. iv223-iv229 |
artikel |
||
| 25 | extranodal lymphoma |
|
19 | S4 |
p. iv186-iv191 |
artikel |
||
| 26 | Extranodal lymphoma: a reappraisal |
Zucca, E. |
|
19 | S4 |
p. iv77-iv80 |
artikel |
|
| 27 | f. hoffmann la roche ltd giving your patients the best chance of cure |
|
19 | S4 |
p. iv261-iv263 |
artikel |
||
| 28 | “focus on…” session: CLL |
|
19 | S4 |
p. iv89-iv90 |
artikel |
||
| 29 | “focus on…” session: lymphoma biology |
|
19 | S4 |
p. iv125-iv126 |
artikel |
||
| 30 | “focus on…” session: new treatments modalities |
|
19 | S4 |
p. iv115-iv116 |
artikel |
||
| 31 | “focus on….” session: PET |
|
19 | S4 |
p. iv123-iv124 |
artikel |
||
| 32 | “focus on…” session: primary mediastinal and other extranodal lymphoma |
|
19 | S4 |
p. iv95-iv96 |
artikel |
||
| 33 | “focus on…” session: profiling and prognosis |
|
19 | S4 |
p. iv93-iv94 |
artikel |
||
| 34 | “focus on…” session: radioimmunotherapy |
|
19 | S4 |
p. iv87-iv88 |
artikel |
||
| 35 | “focus on…” session: T-cell |
|
19 | S4 |
p. iv113-iv114 |
artikel |
||
| 36 | “focus on…” session: transformation |
|
19 | S4 |
p. iv111-iv112 |
artikel |
||
| 37 | “focus on…” session: transplantation |
|
19 | S4 |
p. iv91-iv92 |
artikel |
||
| 38 | Genentech BioOncology |
|
19 | S4 |
p. iv273-iv274 |
artikel |
||
| 39 | glaxosmithkline |
|
19 | S4 |
p. iv259-iv260 |
artikel |
||
| 40 | Hodgkin lymphoma |
|
19 | S4 |
p. iv233-iv237 |
artikel |
||
| 41 | Hodgkin's lymphoma |
|
19 | S4 |
p. iv133-iv137 |
artikel |
||
| 42 | imaging |
|
19 | S4 |
p. iv249-iv251 |
artikel |
||
| 43 | indolent lymphoma |
|
19 | S4 |
p. iv176-iv185 |
artikel |
||
| 44 | Indolent NHL |
|
19 | S4 |
p. iv207-iv211 |
artikel |
||
| 45 | key note lectures |
|
19 | S4 |
p. iv81 |
artikel |
||
| 46 | lymphoma biology |
|
19 | S4 |
p. iv199-iv203 |
artikel |
||
| 47 | lymphoma biology |
|
19 | S4 |
p. iv166-iv170 |
artikel |
||
| 48 | Maintenance treatment in multiple myeloma |
Harousseau, J.L. |
|
19 | S4 |
p. iv54-iv55 |
artikel |
|
| 49 | mantle cell lymphoma |
|
19 | S4 |
p. iv172-iv175 |
artikel |
||
| 50 | mantle cell lymphoma |
|
19 | S4 |
p. iv212-iv215 |
artikel |
||
| 51 | MicroRNAs and lymphomas |
|
19 | S4 |
p. iv39-iv40 |
artikel |
||
| 52 | Millennium Pharmaceuticals Ortho Biotech, a division of Janssen-Cilag emerging therapies for relapsed and refractory lymphoid neoplasms |
|
19 | S4 |
p. iv275 |
artikel |
||
| 53 | miscellaneous |
|
19 | S4 |
p. iv252-iv253 |
artikel |
||
| 54 | multiple myeloma |
|
19 | S4 |
p. iv171 |
artikel |
||
| 55 | multiple myeloma/WM |
|
19 | S4 |
p. iv238 |
artikel |
||
| 56 | mundipharma |
|
19 | S4 |
p. iv265 |
artikel |
||
| 57 | New monoclonal antibodies for non-Hodgkin's lymphoma |
Leonard, J.P. |
|
19 | S4 |
p. iv60-iv62 |
artikel |
|
| 58 | New response criteria for lymphomas in clinical trials |
Cheson, B.D. |
|
19 | S4 |
p. iv35-iv38 |
artikel |
|
| 59 | New targets for lymphoma treatment |
Johnson, P.W.M. |
|
19 | S4 |
p. iv56-iv59 |
artikel |
|
| 60 | new treatment modalities |
|
19 | S4 |
p. iv243 |
artikel |
||
| 61 | new treatment modalities |
|
19 | S4 |
p. iv158-iv163 |
artikel |
||
| 62 | Non-MALT marginal zone lymphomas |
Thieblemont, C. |
|
19 | S4 |
p. iv70-iv73 |
artikel |
|
| 63 | pediatric lymphoma |
|
19 | S4 |
p. iv138-iv140 |
artikel |
||
| 64 | pediatrics |
|
19 | S4 |
p. iv248 |
artikel |
||
| 65 | poster session II, Friday 6 June (Marquee Parlo Ciani) pathology |
|
19 | S4 |
p. iv164-iv165 |
artikel |
||
| 66 | poster session I Thursday 5 June (Marquee Parco Ciani) epidemiology |
|
19 | S4 |
p. iv131-iv132 |
artikel |
||
| 67 | Prognostic factors in chronic lymphocytic leukemia |
Hallek, M. |
|
19 | S4 |
p. iv51-iv53 |
artikel |
|
| 68 | Radiotherapy in non-Hodgkin lymphomas |
Gospodarowicz, M. |
|
19 | S4 |
p. iv47-iv50 |
artikel |
|
| 69 | sanofi aventis |
|
19 | S4 |
p. iv266 |
artikel |
||
| 70 | Satellite Symposia Schedule |
|
19 | S4 |
p. iv8 |
artikel |
||
| 71 | session 14 – biological treatments |
|
19 | S4 |
p. iv129-iv130 |
artikel |
||
| 72 | session 3 – biology and novel rational therapeutic targets in DLBCL |
|
19 | S4 |
p. iv97-iv98 |
artikel |
||
| 73 | session 4 – diffuse large B-cell lymphoma |
|
19 | S4 |
p. iv99-iv100 |
artikel |
||
| 74 | session 6 – extranodal lymphoma |
|
19 | S4 |
p. iv103-iv104 |
artikel |
||
| 75 | session 5 – follicular lymphoma/CLL |
|
19 | S4 |
p. iv101-iv102 |
artikel |
||
| 76 | session 12 – hodgkin's lymphoma |
|
19 | S4 |
p. iv120-iv121 |
artikel |
||
| 77 | session 2 – mantle cell lymphoma |
|
19 | S4 |
p. iv85-iv86 |
artikel |
||
| 78 | session 9 – micro-RNA in lymphoid malignancies |
|
19 | S4 |
p. iv117 |
artikel |
||
| 79 | session 13 – new drugs |
|
19 | S4 |
p. iv127-iv128 |
artikel |
||
| 80 | session 7 – pathology and clinical/pathological correlations |
|
19 | S4 |
p. iv105-iv107 |
artikel |
||
| 81 | session 8 – pediatric lymphoma |
|
19 | S4 |
p. iv108-iv110 |
artikel |
||
| 82 | session 10 – review lectures |
|
19 | S4 |
p. iv118 |
artikel |
||
| 83 | session 11 – special topic: classifying lymphoma |
|
19 | S4 |
p. iv119 |
artikel |
||
| 84 | session 1 – 50th anniversary of Burkitt lymphoma |
|
19 | S4 |
p. iv83-iv84 |
artikel |
||
| 85 | subject index |
|
19 | S4 |
p. iv292-iv296 |
artikel |
||
| 86 | summary of Conference Schedule |
|
19 | S4 |
p. iv6-iv7 |
artikel |
||
| 87 | Table of Contents |
|
19 | S4 |
p. v |
artikel |
||
| 88 | T-cell lymphoma |
|
19 | S4 |
p. iv153-iv157 |
artikel |
||
| 89 | T-cell lymphoma |
|
19 | S4 |
p. iv230-iv232 |
artikel |
||
| 90 | Title Page |
|
19 | S4 |
p. ii |
artikel |
||
| 91 | transplantation |
|
19 | S4 |
p. iv239-iv242 |
artikel |
||
| 92 | Treatment of lymphocyte-predominant Hodgkin lymphoma |
Engert, A. |
|
19 | S4 |
p. iv45-iv46 |
artikel |
|
| 93 | treatment toxicity |
|
19 | S4 |
p. iv244-iv247 |
artikel |
||
| 94 | Update on T-cell lymphoma |
Vose, J.M. |
|
19 | S4 |
p. iv74-iv76 |
artikel |
94 gevonden resultaten